Myeloid Therapeutics

About:

Myeloid Therapeutics is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.

Website: https://www.myeloidtx.com

Twitter/X: MyeloidTx

Top Investors: Alexandria Venture Investments, 8VC, ARCH Venture Partners, Hatteras Venture Partners, Newpath Management

Description:

Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyte approach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.